Substitution arrangement for gliclazide

Ongoing shortages of gliclazide 30mg products prompt department to issue substitution instrument  Pharmacists can now dispense specific 60mg gliclazide oral tablets as alternatives to brands of 30mg formulations.  The department of health and aged care issued the Therapeutic Goods (Serious Scarcity and Substitutable Medicines) (Gliclazide) Instrument 2024 earlier this week (27 February), enabling pharmacists to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Annual Covid boosters confirmed
Next ‘That undercurrent of bullying and harassment’